Search

everythinglearnresearchcommunity

for

Search:↓

FFA patients have fewer melanocytes and thinner skin compared to others.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

Tofacitinib taken by mouth helps treat hair loss in children.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Frontal fibrosing alopecia can mimic traction alopecia but has distinct features like facial papules and eyebrow thinning.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

Sunscreen use is linked to frontal fibrosing alopecia, especially in males.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

The document suggests a possible link between frontal fibrosing alopecia and rosacea.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Frontal fibrosing alopecia can affect African men and may be underdiagnosed.

Brownish halos around axillary hair can help diagnose frontal fibrosing alopecia.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.